CD33 and Alzheimer disease: Over the past decade, genome-wide association studies have revealed a large number of common variants that are associated with a small increased risk of AD, including several genes involved in innate immunity, such as CLU, CR1, PICALM [4] and SIGLEC3 (CD33) [5].